Kite Pharma, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Kite Pharma, Inc. reported Net Income (Loss) Available to Common Stockholders, Basic of -$84.93 million for the 3-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-02-28
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$84.93M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-09-30 was -$73.95M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$64.27M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-03-31 was -$43.92M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for fiscal 2016 was -$267.07M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for fiscal 2015 was -$101.65M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was -$43.66M.
- Kite Pharma, Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was -$7.80M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$84.93M 10-K · filed 2017-02-28 | -$158.88M derived: sum of 2 quarters · filed 2017-02-28 | -$223.15M derived: sum of 3 quarters · filed 2017-02-28 | -$267.07M 10-K · filed 2017-02-28 |
| 2016-09-30 | -$73.95M 10-K · filed 2017-02-28 | -$138.22M derived: sum of 2 quarters · filed 2017-02-28 | -$182.14M derived: sum of 3 quarters · filed 2017-02-28 | -$220.37M derived: sum of 4 quarters · filed 2017-02-28 |
| 2016-06-30 | -$64.27M 10-K · filed 2017-02-28 | -$108.19M derived: sum of 2 quarters · filed 2017-02-28 | -$146.42M derived: sum of 3 quarters · filed 2017-02-28 | -$173.86M derived: sum of 4 quarters · filed 2017-02-28 |
| 2016-03-31 | -$43.92M 10-K · filed 2017-02-28 | -$82.15M derived: sum of 2 quarters · filed 2017-02-28 | -$109.59M derived: sum of 3 quarters · filed 2017-02-28 | -$130.48M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-12-31 | -$38.23M 10-K · filed 2017-02-28 | -$65.67M derived: sum of 2 quarters · filed 2017-02-28 | -$86.56M derived: sum of 3 quarters · filed 2017-02-28 | -$101.65M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$27.44M 10-K · filed 2017-02-28 | -$48.33M derived: sum of 2 quarters · filed 2017-02-28 | -$63.42M 10-Q · filed 2015-11-12 | -$76.44M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$20.89M 10-K · filed 2017-02-28 | -$35.98M 10-Q · filed 2015-08-10 | -$49.00M derived: sum of 3 quarters · filed 2017-02-28 | -$58.05M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$15.09M 10-K · filed 2017-02-28 | -$28.11M derived: sum of 2 quarters · filed 2017-02-28 | -$37.16M derived: sum of 3 quarters · filed 2017-02-28 | -$55.05M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$13.02M 10-K · filed 2016-02-29 | -$22.07M derived: sum of 2 quarters · filed 2016-02-29 | -$39.96M derived: sum of 3 quarters · filed 2016-02-29 | -$43.66M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$9.05M 10-K · filed 2016-02-29 | -$26.94M derived: sum of 2 quarters · filed 2016-02-29 | -$30.64M 10-Q · filed 2015-11-12 | -$33.59M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$17.89M 10-K · filed 2016-02-29 | -$21.59M 10-Q · filed 2015-08-10 | -$24.54M derived: sum of 3 quarters · filed 2016-02-29 | -$26.59M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$3.70M 10-K · filed 2016-02-29 | -$6.65M derived: sum of 2 quarters · filed 2016-02-29 | -$8.70M derived: sum of 3 quarters · filed 2016-02-29 | -$10.44M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$2.95M 10-K · filed 2015-03-26 | -$5.01M derived: sum of 2 quarters · filed 2015-03-26 | -$6.74M derived: sum of 3 quarters · filed 2015-03-26 | -$7.80M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$2.05M 10-K · filed 2015-03-26 | -$3.79M derived: sum of 2 quarters · filed 2015-03-26 | -$4.85M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$1.73M 10-K · filed 2015-03-26 | -$2.79M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$1.06M 10-K · filed 2015-03-26 | |||
| 2012-12-31 | -$2.57M 10-K · filed 2015-03-26 |